Knowledge (XXG)

Ibandronic acid

Source 📝

612: 589: 2427: 965: 42: 2455: 850:(FDA) issued a communication warning of the possibility of severe and sometimes incapacitating bone, joint or muscle pain. A study conducted by the American Society of Bone and Mineral Research concluded that long-term use of 1443: 135: 190: 1360: 742: 835:. At the study's conclusion, both doses significantly reduced the occurrence risk of new vertebral fractures by 50–52 percent when compared to the effects of the placebo drug. 2485: 1436: 1334: 1257:"Information for Healthcare Professionals: Bisphosphonates (marketed as Actonel, Actonel+Ca, Aredia, Boniva, Didronel, Fosamax, Fosamax+D, Reclast, Skelid, and Zometa)" 2364: 2490: 1429: 64: 698: 101: 684: 1832: 2357: 838:
Ibandronate is efficacious for the prevention of metastasis-related bone fractures in multiple myeloma, breast cancer, and certain other cancers.
1327: 2495: 1278:
Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, et al. (American Society for Bone and Mineral Research) (November 2010).
1256: 1213:
Sittig HB (2012). "Pathogenesis and bisphosphonate treatment of skeletal events and bone pain in metastatic cancer: focus on ibandronate".
1280:"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research" 1025:
Ibandronic acid is sold under the brand names Boniva, Bondronat, Bonviva, Bandrone, Ibandrix, Adronil, Bondrova, Bonprove, and Fosfonat.
2500: 1974: 1747: 1649: 1367: 2371: 1401: 1172: 1012: 718: 131: 2378: 986: 1338: 811:(FDA) approved ibandronate as a daily treatment for post-menopausal osteoporosis. The basis for this approval was a three-year, 2395: 2304: 330: 220: 82: 854:, including Boniva, may increase the risk of a rare but serious fracture of the femur. The drug also has been associated with 118: 2350: 990: 1712: 2445: 1554: 847: 808: 807:
Ibandronate is indicated for the treatment and prevention of osteoporosis in post-menopausal women. In May 2003, the US
452: 1892: 812: 568: 975: 1546: 779: 994: 979: 2069: 96: 726:
InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)
2480: 2406: 2299: 2073: 1956: 1842: 1742: 855: 1852: 401: 1837: 1587: 172: 607: 2123: 1912: 1882: 275: 2400: 1827: 1321: 392: 1122:"Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis" 529: 1752: 297: 1797: 796: 584: 347: 183: 179: 1597: 1309: 1238: 770:
and metastasis-associated skeletal fractures in people with cancer. It may also be used to treat
146: 550: 2156: 1705: 1652: 1407: 1397: 1301: 1230: 1168: 1162: 1143: 1042: 540: 509: 235: 54: 1421: 2430: 2255: 2143: 1291: 1222: 1133: 1094: 1068: 827:
women with post-menopausal osteoporosis. Each participant also received daily oral doses of
786: 624: 356: 257: 461: 441: 2475: 2459: 2283: 2245: 2240: 1762: 1559: 1534: 1514: 1509: 1504: 1499: 1494: 1489: 1479: 938: 928: 910: 900: 890: 851: 287: 265: 74: 611: 588: 2319: 2265: 2230: 2064: 1529: 1524: 1466: 1138: 1121: 880: 824: 771: 763: 2469: 2314: 2235: 1902: 1897: 1802: 1657: 600: 1313: 2324: 2309: 2260: 2029: 1698: 1662: 1457: 1453: 1242: 816: 767: 203: 198: 17: 381: 2273: 2250: 1922: 1635: 1627: 1580: 964: 33: 2329: 2278: 2186: 2138: 1952: 1942: 1937: 1927: 1807: 1669: 1642: 1620: 1188: 660: 432: 41: 1411: 2412: 2196: 2176: 2133: 2128: 2108: 2103: 2044: 2014: 1994: 1947: 1932: 1917: 1679: 1612: 832: 310: 68: 1305: 1234: 1147: 2181: 2171: 2166: 2161: 2118: 2054: 2049: 2024: 2004: 1989: 1984: 1887: 1474: 1337:. Journal of Bone and Mineral Research. 14 September 2010. Archived from 412: 113: 421: 2151: 2113: 2095: 2059: 2019: 1999: 1979: 1847: 1822: 1817: 1812: 1721: 1674: 828: 820: 775: 367: 1335:"JBMR Publishes ASBMR Task Force Report on Atypical Femoral Fractures" 1226: 2191: 2039: 2034: 2009: 1777: 1757: 1361:"Osteonecrosis of the jaw (ONJ) and drug treatments for osteoporosis" 1296: 1279: 783: 520: 315: 100: 1366:. United Kingdom: The National Osteoporosis Society. Archived from 489: 481: 1605: 1396:(Seventh ed.). New Delhi: Jaypee Brothers Medical Publisher. 683: 674: 556: 500: 2201: 472: 241: 91: 1694: 1425: 229: 125: 108: 958: 573: 157: 749: 1690: 2443: 2388: 2342: 2292: 2221: 2214: 2088: 1967: 1875: 1868: 1861: 1788: 1772: 1735: 1728: 1568: 1545: 1465: 766:medication used in the prevention and treatment of 672: 659: 623: 618: 599: 567: 539: 519: 499: 471: 451: 431: 411: 400: 391: 366: 346: 321: 309: 296: 286: 274: 264: 256: 219: 214: 189: 171: 145: 81: 63: 53: 48: 1193:The American Society of Health-System Pharmacists 380: 2365:GlaxoSmithKline Services Unlimited v Commission 355: 130: 1706: 1437: 8: 117: 32: 993:. Unsourced material may be challenged and 249:In general: ℞ (Prescription only) 2486:Farnesyl pyrophosphate synthase inhibitors 2218: 1872: 1865: 1732: 1713: 1699: 1691: 1444: 1430: 1422: 610: 587: 440: 40: 1295: 1137: 1126:Therapeutics and Clinical Risk Management 1013:Learn how and when to remove this message 858:, relatively rare but serious condition. 460: 865: 2450: 2358:Christopher v. SmithKline Beecham Corp. 1034: 723: 703: 583: 420: 335: 1319: 1167:. John Wiley & Sons. p. 523. 799:and approved for medical use in 1996. 601: 338:Hydroxy--1-phosphonopropyl]phosphinate 31: 1833:Recherche et Industrie Thérapeutiques 549: 528: 508: 73: 7: 2491:Drugs developed by Hoffmann-La Roche 1284:Journal of Bone and Mineral Research 991:adding citations to reliable sources 555: 202: 1748:GlaxoSmithKline Pharmaceuticals Ltd 1650:Parathyroid hormone-related protein 1259:. U.S. Food and Drug Administration 1120:Bauss F, Schimmer RC (March 2006). 706:O=P(O)(O)C(O)(CCN(CCCCC)C)P(=O)(O)O 488: 480: 371: 1394:Essentials of Medical Pharmacology 1326:: CS1 maint: overridden setting ( 650: 59:Boniva, Bonviva, Bondronat, others 25: 2372:United States v. Glaxo Group Ltd. 1392:Tripathi KD (30 September 2013). 2453: 2426: 2425: 2379:United States v. GlaxoSmithKline 963: 641: 635: 2396:Drug Industry Documents Archive 1161:Fischer J, Ganellin CR (2006). 1099:European Medicines Agency (EMA) 1073:European Medicines Agency (EMA) 1047:European Medicines Agency (EMA) 731:Key:MPBVHIBUJCELCL-UHFFFAOYSA-N 2351:Canada v. GlaxoSmithKline Inc. 644: 629: 1: 1164:Analogue-based Drug Discovery 2496:Drugs developed by Genentech 848:Food and Drug Administration 809:Food and Drug Administration 1547:Bone morphogenetic proteins 795:It was patented in 1986 by 2517: 2501:Drugs developed by GSK plc 778:levels). It is typically 619:Chemical and physical data 2421: 1853:Smith, Kline & French 739: 714: 694: 326: 282:(concentration-dependent) 39: 1843:S. E. Massengill Company 1743:GlaxoSmithKline Pakistan 856:osteonecrosis of the jaw 1838:Reliant Pharmaceuticals 1588:Aluminium chlorohydrate 1452:Drugs for treatment of 1593:Dual action bone agent 2401:GlaxoSmithKline Prize 1828:Human Genome Sciences 1798:Allen & Hanburys 1753:Stiefel Laboratories 1576:Resorption inhibitor 987:improve this section 950:Society and culture 868: 797:Boehringer Mannheim 36: 18:Boniva (medication) 2305:Silas M. Burroughs 1848:SmithKline Beecham 1813:Burroughs Wellcome 1598:Strontium ranelate 1332:; Lay summary in: 1075:. 23 February 2004 866: 790:ibandronate sodium 136:Ibandronate_sodium 119:Ibandronate_sodium 2441: 2440: 2338: 2337: 2210: 2209: 2084: 2083: 1784: 1783: 1688: 1687: 1290:(11): 2267–2294. 1227:10.1159/000338947 1101:. 21 January 2011 1023: 1022: 1015: 947: 946: 875:Relative potency 867:Relative potency 757: 756: 685:Interactive image 569:CompTox Dashboard 245: 233: 161: 128: 111: 94: 27:Chemical compound 16:(Redirected from 2508: 2458: 2457: 2456: 2449: 2429: 2428: 2256:Patrick Vallance 2219: 1948:Wellbutrin/Zyban 1873: 1866: 1733: 1715: 1708: 1701: 1692: 1521:Non-nitrogenous 1446: 1439: 1432: 1423: 1416: 1415: 1389: 1383: 1382: 1380: 1378: 1372: 1365: 1357: 1351: 1350: 1348: 1346: 1331: 1325: 1317: 1299: 1297:10.1002/jbmr.253 1275: 1269: 1268: 1266: 1264: 1253: 1247: 1246: 1210: 1204: 1203: 1201: 1199: 1185: 1179: 1178: 1158: 1152: 1151: 1141: 1117: 1111: 1110: 1108: 1106: 1091: 1085: 1084: 1082: 1080: 1065: 1059: 1058: 1056: 1054: 1043:"Bondronat EPAR" 1039: 1018: 1011: 1007: 1004: 998: 967: 959: 869: 846:In 2008, the US 774:(elevated blood 753: 752: 745: 687: 667: 652: 646: 643: 637: 631: 614: 603: 592: 591: 577: 575: 559: 553: 532: 512: 492: 484: 464: 444: 424: 404: 384: 374: 373: 359: 301: 243: 240: 231: 228: 206: 159: 156: 138: 127: 124: 121: 110: 107: 104: 93: 90: 77: 44: 37: 35: 21: 2516: 2515: 2511: 2510: 2509: 2507: 2506: 2505: 2481:Bisphosphonates 2466: 2465: 2464: 2454: 2452: 2444: 2442: 2437: 2417: 2384: 2334: 2288: 2284:Laurie Glimcher 2251:Manvinder Banga 2246:Roy M. Anderson 2241:Simon Dingemans 2223: 2206: 2080: 1963: 1857: 1790: 1780: 1768: 1763:ViiV Healthcare 1724: 1719: 1689: 1684: 1564: 1560:Eptotermin alfa 1555:Dibotermin alfa 1541: 1535:Tiludronic acid 1515:Zoledronic acid 1510:Risedronic acid 1505:Pamidronic acid 1500:Neridronic acid 1495:Minodronic acid 1490:Incadronic acid 1485:Ibandronic acid 1480:Alendronic acid 1467:Bisphosphonates 1461: 1450: 1420: 1419: 1404: 1391: 1390: 1386: 1376: 1374: 1373:on 17 June 2017 1370: 1363: 1359: 1358: 1354: 1344: 1342: 1341:on 9 April 2016 1333: 1318: 1277: 1276: 1272: 1262: 1260: 1255: 1254: 1250: 1212: 1211: 1207: 1197: 1195: 1187: 1186: 1182: 1175: 1160: 1159: 1155: 1119: 1118: 1114: 1104: 1102: 1093: 1092: 1088: 1078: 1076: 1067: 1066: 1062: 1052: 1050: 1041: 1040: 1036: 1031: 1019: 1008: 1002: 999: 984: 968: 957: 952: 872:Bisphosphonate 864: 852:bisphosphonates 844: 842:Adverse effects 831:and 400IUs of 805: 760:Ibandronic acid 748: 746: 743:(what is this?) 740: 735: 732: 727: 722: 721: 710: 707: 702: 701: 690: 665: 655: 649: 640: 634: 595: 571: 563: 535: 515: 495: 467: 447: 427: 407: 387: 370: 362: 342: 339: 334: 333: 299: 281: 276:Protein binding 266:Bioavailability 258:Pharmacokinetic 252: 210: 174: 167: 148: 141: 34:Ibandronic acid 28: 23: 22: 15: 12: 11: 5: 2514: 2512: 2504: 2503: 2498: 2493: 2488: 2483: 2478: 2468: 2467: 2463: 2462: 2439: 2438: 2436: 2435: 2422: 2419: 2418: 2416: 2415: 2410: 2403: 2398: 2392: 2390: 2386: 2385: 2383: 2382: 2375: 2368: 2361: 2354: 2346: 2344: 2340: 2339: 2336: 2335: 2333: 2332: 2327: 2322: 2320:Henry Wellcome 2317: 2312: 2307: 2302: 2300:Thomas Beecham 2296: 2294: 2290: 2289: 2287: 2286: 2281: 2276: 2271: 2268: 2266:Lynn Elsenhans 2263: 2258: 2253: 2248: 2243: 2238: 2233: 2231:Philip Hampton 2227: 2225: 2216: 2212: 2211: 2208: 2207: 2205: 2204: 2199: 2194: 2189: 2184: 2179: 2174: 2169: 2164: 2159: 2157:Goody's Powder 2154: 2149: 2146: 2141: 2136: 2131: 2126: 2121: 2116: 2111: 2106: 2101: 2098: 2092: 2090: 2086: 2085: 2082: 2081: 2079: 2078: 2067: 2062: 2057: 2052: 2047: 2042: 2037: 2032: 2027: 2022: 2017: 2012: 2007: 2002: 1997: 1992: 1987: 1982: 1977: 1971: 1969: 1965: 1964: 1962: 1961: 1950: 1945: 1940: 1935: 1930: 1925: 1920: 1915: 1910: 1905: 1900: 1895: 1890: 1885: 1879: 1877: 1870: 1863: 1859: 1858: 1856: 1855: 1850: 1845: 1840: 1835: 1830: 1825: 1823:Glaxo Wellcome 1820: 1815: 1810: 1805: 1800: 1794: 1792: 1786: 1785: 1782: 1781: 1776: 1774: 1770: 1769: 1767: 1766: 1760: 1755: 1750: 1745: 1739: 1737: 1730: 1726: 1725: 1720: 1718: 1717: 1710: 1703: 1695: 1686: 1685: 1683: 1682: 1677: 1672: 1667: 1666: 1665: 1660: 1647: 1646: 1645: 1632: 1631: 1630: 1617: 1616: 1615: 1602: 1601: 1600: 1590: 1585: 1584: 1583: 1572: 1570: 1566: 1565: 1563: 1562: 1557: 1551: 1549: 1543: 1542: 1540: 1539: 1538: 1537: 1532: 1530:Clodronic acid 1527: 1525:Etidronic acid 1519: 1518: 1517: 1512: 1507: 1502: 1497: 1492: 1487: 1482: 1471: 1469: 1463: 1462: 1451: 1449: 1448: 1441: 1434: 1426: 1418: 1417: 1402: 1384: 1352: 1270: 1248: 1205: 1180: 1173: 1153: 1112: 1095:"Iasibon EPAR" 1086: 1069:"Bonviva EPAR" 1060: 1049:. 25 June 1996 1033: 1032: 1030: 1027: 1021: 1020: 971: 969: 962: 956: 953: 951: 948: 945: 944: 941: 935: 934: 931: 925: 924: 921: 917: 916: 913: 907: 906: 903: 897: 896: 893: 887: 886: 883: 877: 876: 873: 863: 860: 843: 840: 804: 801: 764:bisphosphonate 755: 754: 737: 736: 734: 733: 730: 728: 725: 717: 716: 715: 712: 711: 709: 708: 705: 697: 696: 695: 692: 691: 689: 688: 680: 678: 670: 669: 663: 657: 656: 653: 647: 638: 632: 627: 621: 620: 616: 615: 605: 597: 596: 594: 593: 580: 578: 565: 564: 562: 561: 545: 543: 537: 536: 534: 533: 525: 523: 517: 516: 514: 513: 505: 503: 497: 496: 494: 493: 487:as salt:  485: 477: 475: 469: 468: 466: 465: 457: 455: 449: 448: 446: 445: 437: 435: 429: 428: 426: 425: 417: 415: 409: 408: 406: 405: 397: 395: 389: 388: 386: 385: 377: 375: 364: 363: 361: 360: 352: 350: 344: 343: 341: 340: 337: 329: 328: 327: 324: 323: 319: 318: 313: 307: 306: 305:10 to 60 hours 303: 294: 293: 290: 284: 283: 278: 272: 271: 268: 262: 261: 254: 253: 251: 250: 247: 238: 225: 223: 217: 216: 212: 211: 209: 208: 195: 193: 187: 186: 177: 175:administration 169: 168: 166: 165: 163: 153: 151: 143: 142: 140: 139: 122: 105: 87: 85: 79: 78: 71: 61: 60: 57: 51: 50: 46: 45: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 2513: 2502: 2499: 2497: 2494: 2492: 2489: 2487: 2484: 2482: 2479: 2477: 2474: 2473: 2471: 2461: 2451: 2447: 2434: 2433: 2424: 2423: 2420: 2414: 2411: 2409: 2408: 2404: 2402: 2399: 2397: 2394: 2393: 2391: 2387: 2381: 2380: 2376: 2374: 2373: 2369: 2367: 2366: 2362: 2360: 2359: 2355: 2353: 2352: 2348: 2347: 2345: 2341: 2331: 2328: 2326: 2323: 2321: 2318: 2316: 2315:John K. Smith 2313: 2311: 2308: 2306: 2303: 2301: 2298: 2297: 2295: 2291: 2285: 2282: 2280: 2277: 2275: 2272: 2270:Jesse Goodman 2269: 2267: 2264: 2262: 2259: 2257: 2254: 2252: 2249: 2247: 2244: 2242: 2239: 2237: 2236:Emma Walmsley 2234: 2232: 2229: 2228: 2226: 2220: 2217: 2213: 2203: 2200: 2198: 2195: 2193: 2190: 2188: 2185: 2183: 2180: 2178: 2175: 2173: 2170: 2168: 2165: 2163: 2160: 2158: 2155: 2153: 2150: 2147: 2145: 2142: 2140: 2137: 2135: 2132: 2130: 2127: 2125: 2122: 2120: 2117: 2115: 2112: 2110: 2107: 2105: 2102: 2099: 2097: 2094: 2093: 2091: 2087: 2077: 2076: 2071: 2068: 2066: 2063: 2061: 2058: 2056: 2053: 2051: 2048: 2046: 2043: 2041: 2038: 2036: 2033: 2031: 2028: 2026: 2023: 2021: 2018: 2016: 2013: 2011: 2008: 2006: 2003: 2001: 1998: 1996: 1993: 1991: 1988: 1986: 1983: 1981: 1978: 1976: 1973: 1972: 1970: 1966: 1960: 1959: 1954: 1951: 1949: 1946: 1944: 1941: 1939: 1936: 1934: 1931: 1929: 1928:Paxil/Seroxat 1926: 1924: 1921: 1919: 1916: 1914: 1911: 1909: 1906: 1904: 1901: 1899: 1896: 1894: 1891: 1889: 1886: 1884: 1881: 1880: 1878: 1874: 1871: 1867: 1864: 1860: 1854: 1851: 1849: 1846: 1844: 1841: 1839: 1836: 1834: 1831: 1829: 1826: 1824: 1821: 1819: 1816: 1814: 1811: 1809: 1806: 1804: 1803:Beecham Group 1801: 1799: 1796: 1795: 1793: 1789:Predecessors, 1787: 1779: 1775: 1771: 1764: 1761: 1759: 1756: 1754: 1751: 1749: 1746: 1744: 1741: 1740: 1738: 1734: 1731: 1727: 1723: 1716: 1711: 1709: 1704: 1702: 1697: 1696: 1693: 1681: 1678: 1676: 1673: 1671: 1668: 1664: 1661: 1659: 1658:Abaloparatide 1656: 1655: 1654: 1651: 1648: 1644: 1641: 1640: 1639: 1637: 1633: 1629: 1626: 1625: 1624: 1622: 1618: 1614: 1611: 1610: 1609: 1607: 1603: 1599: 1596: 1595: 1594: 1591: 1589: 1586: 1582: 1579: 1578: 1577: 1574: 1573: 1571: 1567: 1561: 1558: 1556: 1553: 1552: 1550: 1548: 1544: 1536: 1533: 1531: 1528: 1526: 1523: 1522: 1520: 1516: 1513: 1511: 1508: 1506: 1503: 1501: 1498: 1496: 1493: 1491: 1488: 1486: 1483: 1481: 1478: 1477: 1476: 1473: 1472: 1470: 1468: 1464: 1459: 1455: 1454:bone diseases 1447: 1442: 1440: 1435: 1433: 1428: 1427: 1424: 1413: 1409: 1405: 1403:9789350259375 1399: 1395: 1388: 1385: 1369: 1362: 1356: 1353: 1340: 1336: 1329: 1323: 1315: 1311: 1307: 1303: 1298: 1293: 1289: 1285: 1281: 1274: 1271: 1258: 1252: 1249: 1244: 1240: 1236: 1232: 1228: 1224: 1220: 1216: 1209: 1206: 1194: 1190: 1184: 1181: 1176: 1174:9783527607495 1170: 1166: 1165: 1157: 1154: 1149: 1145: 1140: 1135: 1131: 1127: 1123: 1116: 1113: 1100: 1096: 1090: 1087: 1074: 1070: 1064: 1061: 1048: 1044: 1038: 1035: 1028: 1026: 1017: 1014: 1006: 996: 992: 988: 982: 981: 977: 972:This section 970: 966: 961: 960: 954: 949: 942: 940: 937: 936: 932: 930: 927: 926: 922: 919: 918: 914: 912: 909: 908: 904: 902: 899: 898: 894: 892: 889: 888: 884: 882: 879: 878: 874: 871: 870: 861: 859: 857: 853: 849: 841: 839: 836: 834: 830: 826: 822: 818: 814: 810: 802: 800: 798: 793: 791: 788: 785: 781: 777: 773: 772:hypercalcemia 769: 765: 761: 751: 744: 738: 729: 724: 720: 713: 704: 700: 693: 686: 682: 681: 679: 676: 671: 664: 662: 658: 628: 626: 622: 617: 613: 609: 606: 604: 602:ECHA InfoCard 598: 590: 586: 585:DTXSID5048340 582: 581: 579: 570: 566: 558: 557:RCSB PDB 552: 547: 546: 544: 542: 538: 531: 527: 526: 524: 522: 518: 511: 507: 506: 504: 502: 498: 491: 486: 483: 479: 478: 476: 474: 470: 463: 459: 458: 456: 454: 450: 443: 439: 438: 436: 434: 430: 423: 419: 418: 416: 414: 410: 403: 399: 398: 396: 394: 390: 383: 379: 378: 376: 369: 365: 358: 354: 353: 351: 349: 345: 336: 332: 325: 320: 317: 314: 312: 308: 304: 302: 295: 291: 289: 285: 280:90.9 to 99.5% 279: 277: 273: 269: 267: 263: 259: 255: 248: 246: Rx-only 239: 237: 227: 226: 224: 222: 218: 213: 205: 200: 197: 196: 194: 192: 188: 185: 181: 178: 176: 170: 164: 155: 154: 152: 150: 144: 137: 133: 123: 120: 115: 106: 103: 98: 89: 88: 86: 84: 80: 76: 72: 70: 66: 62: 58: 56: 52: 49:Clinical data 47: 43: 38: 30: 19: 2431: 2407:Side Effects 2405: 2377: 2370: 2363: 2356: 2349: 2325:Andrew Witty 2310:Mahlon Kline 2261:Vivienne Cox 2074: 2030:H5N1 vaccine 1957: 1907: 1791:acquisitions 1729:Subsidiaries 1663:Teriparatide 1634: 1619: 1604: 1592: 1575: 1484: 1393: 1387: 1375:. Retrieved 1368:the original 1355: 1343:. Retrieved 1339:the original 1322:cite journal 1287: 1283: 1273: 1261:. Retrieved 1251: 1221:(6): 380–7. 1218: 1214: 1208: 1196:. Retrieved 1192: 1183: 1163: 1156: 1129: 1125: 1115: 1103:. Retrieved 1098: 1089: 1077:. Retrieved 1072: 1063: 1051:. Retrieved 1046: 1037: 1024: 1009: 1000: 985:Please help 973: 920:Ibandronate 862:Pharmacology 845: 837: 823:-controlled 817:double-blind 806: 803:Medical uses 794: 789: 768:osteoporosis 759: 758: 747:   741:   298:Elimination 221:Legal status 215:Legal status 83:License data 29: 2274:Judy Lewent 1636:Cathepsin K 1628:Romosozumab 1581:Ipriflavone 1475:Nitrogenous 1132:(1): 3–18. 1003:August 2024 955:Brand names 939:Zoledronate 929:Risedronate 911:Alendronate 901:Pamidronate 891:Tiludronate 668: g·mol 608:100.214.537 510:CHEBI:93770 357:114084-78-5 322:Identifiers 184:intravenous 55:Trade names 2470:Categories 2343:Litigation 2330:Chris Gent 2279:Urs Rohner 2187:Parodontax 1995:Engerix-B 1808:Block Drug 1670:Calcitonin 1643:Odanacatib 1621:Sclerostin 1345:27 October 1263:27 October 1029:References 881:Etidronate 813:randomized 780:formulated 673:3D model ( 661:Molar mass 541:PDB ligand 462:UMD7G2653W 433:ChemSpider 393:IUPHAR/BPS 348:CAS Number 331:IUPAC name 288:Metabolism 2413:Study 329 2224:Directors 2222:Board of 2197:Sensodyne 2177:Nicorette 2134:Emergen-C 2129:ChapStick 2109:BC Powder 2104:Aquafresh 2045:Pandemrix 2015:Hepatyrix 1913:Flixonase 1893:Augmentin 1680:Vitamin D 1653:analogues 1638:inhibitor 1623:inhibitor 1613:Denosumab 1608:inhibitor 1412:868299888 1377:14 August 1215:Onkologie 1105:30 August 1079:28 August 1053:28 August 974:does not 923:500-1000 833:vitamin D 530:ChEMBL997 311:Excretion 300:half-life 173:Routes of 147:Pregnancy 75:Monograph 69:Drugs.com 2460:Medicine 2432:Category 2182:NiQuitin 2172:Nicoderm 2167:Lucozade 2162:Horlicks 2144:Excedrin 2119:Caltrate 2065:Shingrix 2055:Rabavert 2050:Pediarix 2025:Infanrix 2005:FluLaval 1990:Cervarix 1985:Boostrix 1968:Vaccines 1943:Ventolin 1933:Serlipet 1923:Lamictal 1918:Hycamtin 1903:Beconase 1862:Products 1314:15194275 1306:20842676 1235:22722461 1189:"Boniva" 1148:18360577 915:100-500 750:(verify) 413:DrugBank 191:ATC code 180:By mouth 162: B3 149:category 114:DailyMed 2152:Geritol 2148:Flonase 2124:Centrum 2114:Biotene 2096:Actifed 2070:Twinrix 2060:Rotarix 2020:Hiberix 2000:Fluarix 1980:Bexsero 1938:Tagamet 1898:Avandia 1869:Current 1736:Current 1675:Calcium 1243:8413102 1198:3 April 1139:1661644 995:removed 980:sources 829:calcium 821:placebo 782:as its 776:calcium 666:319.231 625:Formula 422:DB00710 368:PubChem 207:) 201: ( 199:M05BA06 134::  116::  99::  2476:Amines 2446:Portal 2215:People 2192:Ribena 2089:Former 2040:Menveo 2035:Kinrix 2010:Havrix 1975:Arexvy 1953:Zantac 1908:Boniva 1883:Advair 1876:Pharma 1778:Haleon 1773:Former 1758:Tesaro 1410:  1400:  1312:  1304:  1241:  1233:  1171:  1146:  1136:  784:sodium 699:SMILES 521:ChEMBL 490:D04486 482:D08056 316:Kidney 236:℞-only 234: 129:  112:  102:by INN 95:  2389:Other 2293:Other 2100:Advil 1818:Glaxo 1765:(85%) 1606:RANKL 1569:Other 1371:(PDF) 1364:(PDF) 1310:S2CID 1239:S2CID 943:5000 933:1000 825:trial 762:is a 719:InChI 675:JSmol 548:BFQ ( 501:ChEBI 442:54839 382:60852 2202:Tums 2075:more 1958:more 1888:Alli 1408:OCLC 1398:ISBN 1379:2018 1347:2010 1328:link 1302:PMID 1265:2010 1231:PMID 1200:2011 1169:ISBN 1144:PMID 1107:2024 1081:2024 1055:2024 978:any 976:cite 905:100 787:salt 551:PDBe 473:KEGG 453:UNII 402:3059 270:0.6% 260:data 65:AHFS 2139:Eno 1722:GSK 1458:M05 1292:doi 1223:doi 1134:PMC 989:by 895:10 574:EPA 372:CID 292:Nil 204:WHO 132:FDA 97:EMA 2472:: 2072:… 1955:… 1406:. 1324:}} 1320:{{ 1308:. 1300:. 1288:25 1286:. 1282:. 1237:. 1229:. 1219:35 1217:. 1191:. 1142:. 1128:. 1124:. 1097:. 1071:. 1045:. 885:1 819:, 815:, 792:. 639:23 554:, 242:EU 230:US 182:, 158:AU 126:US 109:US 92:EU 2448:: 1714:e 1707:t 1700:v 1460:) 1456:( 1445:e 1438:t 1431:v 1414:. 1381:. 1349:. 1330:) 1316:. 1294:: 1267:. 1245:. 1225:: 1202:. 1177:. 1150:. 1130:2 1109:. 1083:. 1057:. 1016:) 1010:( 1005:) 1001:( 997:. 983:. 677:) 654:2 651:P 648:7 645:O 642:N 636:H 633:9 630:C 576:) 572:( 560:) 244:: 232:: 160:: 67:/ 20:)

Index

Boniva (medication)

Trade names
AHFS
Drugs.com
Monograph
License data
EMA
by INN
DailyMed
Ibandronate_sodium
FDA
Ibandronate_sodium
Pregnancy
category

Routes of
administration

By mouth
intravenous
ATC code
M05BA06
WHO
Legal status
℞-only
Pharmacokinetic
Bioavailability
Protein binding
Metabolism
Elimination half-life
Excretion
Kidney
IUPAC name

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.